A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 262 participants.

Also called NCT02175784

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 262 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02175784
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02175784. Randomized; quadruple masking; primary purpose treatment. Start 2014-03-31 (actual); primary completion 2015-03-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
ipragliflozin
Intervention (Drug)
placebo
Lead sponsor
Astellas Pharma Inc (class: industry)

Record details

Record id
cardio:ct-nct02175784
Content hash
ff140ecd10e044bacdc580cacf569b6859b278b4270d940efdbcf6d6ba7a0d1e